Barriers to hematopoietic cell transplantation clinical trial participation of African American and black youth with sickle cell disease and their parents

Nancy A. Omondi, Stacy E Stickney Ferguson, Navneet S. Majhail, Ellen M. Denzen, George R. Buchanan, Ann E. Haight, Richard J. Labotka, J. Douglas Rizzo, Elizabeth A. Murphy

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

African Americans and Blacks have low participation rates in clinical trials and reduced access to aggressive medical therapies. Hematopoietic cell transplantation (HCT) is a high-risk but potentially curative therapy for sickle cell disease (SCD), a disorder predominantly seen in African Americans. We conducted focus groups to better understand participation barriers to HCT clinical trials for SCD. Nine focus groups of youth with SCD (n=10) and parents (n=41) were conducted at 3 sites representing the Midwest, South Atlantic, and West South Central US. Main barriers to clinical trial participation included gaps in knowledge about SCD, limited access to SCD/HCT trial information, and mistrust of medical professionals. For education about SCD/HCT trials, participants highly preferred one-on-one interactions with medical professionals and electronic media as a supplement. Providers can engage with sickle cell camps to provide information on SCD/HCT clinical trials to youth and local health fairs for parents/families. Youth reported learning about SCD through computer games; investigators may find this medium useful for clinical trial/HCT education. African Americans affected by SCD face unique barriers to clinical trial participation and have unmet HCT clinical studies education needs. Greater recognition of these barriers will allow targeted interventions in this community to increase their access to HCT.

Original languageEnglish (US)
Pages (from-to)289-298
Number of pages10
JournalJournal of Pediatric Hematology/Oncology
Volume35
Issue number4
DOIs
StatePublished - May 2013

Fingerprint

Cell Transplantation
Sickle Cell Anemia
African Americans
Parents
Clinical Trials
Focus Groups
Education
Health Fairs
Medical Electronics
Video Games
Research Personnel
Learning
Therapeutics

Keywords

  • Clinical trial participation
  • Focus groups
  • Hematopoietic cell transplantation
  • Mistrust
  • Sickle cell disease

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Oncology
  • Hematology

Cite this

Barriers to hematopoietic cell transplantation clinical trial participation of African American and black youth with sickle cell disease and their parents. / Omondi, Nancy A.; Ferguson, Stacy E Stickney; Majhail, Navneet S.; Denzen, Ellen M.; Buchanan, George R.; Haight, Ann E.; Labotka, Richard J.; Rizzo, J. Douglas; Murphy, Elizabeth A.

In: Journal of Pediatric Hematology/Oncology, Vol. 35, No. 4, 05.2013, p. 289-298.

Research output: Contribution to journalArticle

Omondi, Nancy A. ; Ferguson, Stacy E Stickney ; Majhail, Navneet S. ; Denzen, Ellen M. ; Buchanan, George R. ; Haight, Ann E. ; Labotka, Richard J. ; Rizzo, J. Douglas ; Murphy, Elizabeth A. / Barriers to hematopoietic cell transplantation clinical trial participation of African American and black youth with sickle cell disease and their parents. In: Journal of Pediatric Hematology/Oncology. 2013 ; Vol. 35, No. 4. pp. 289-298.
@article{d31f98a43097463aab5cb534ffb4ad69,
title = "Barriers to hematopoietic cell transplantation clinical trial participation of African American and black youth with sickle cell disease and their parents",
abstract = "African Americans and Blacks have low participation rates in clinical trials and reduced access to aggressive medical therapies. Hematopoietic cell transplantation (HCT) is a high-risk but potentially curative therapy for sickle cell disease (SCD), a disorder predominantly seen in African Americans. We conducted focus groups to better understand participation barriers to HCT clinical trials for SCD. Nine focus groups of youth with SCD (n=10) and parents (n=41) were conducted at 3 sites representing the Midwest, South Atlantic, and West South Central US. Main barriers to clinical trial participation included gaps in knowledge about SCD, limited access to SCD/HCT trial information, and mistrust of medical professionals. For education about SCD/HCT trials, participants highly preferred one-on-one interactions with medical professionals and electronic media as a supplement. Providers can engage with sickle cell camps to provide information on SCD/HCT clinical trials to youth and local health fairs for parents/families. Youth reported learning about SCD through computer games; investigators may find this medium useful for clinical trial/HCT education. African Americans affected by SCD face unique barriers to clinical trial participation and have unmet HCT clinical studies education needs. Greater recognition of these barriers will allow targeted interventions in this community to increase their access to HCT.",
keywords = "Clinical trial participation, Focus groups, Hematopoietic cell transplantation, Mistrust, Sickle cell disease",
author = "Omondi, {Nancy A.} and Ferguson, {Stacy E Stickney} and Majhail, {Navneet S.} and Denzen, {Ellen M.} and Buchanan, {George R.} and Haight, {Ann E.} and Labotka, {Richard J.} and Rizzo, {J. Douglas} and Murphy, {Elizabeth A.}",
year = "2013",
month = "5",
doi = "10.1097/MPH.0b013e31828d5e6a",
language = "English (US)",
volume = "35",
pages = "289--298",
journal = "Journal of Pediatric Hematology/Oncology",
issn = "1077-4114",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Barriers to hematopoietic cell transplantation clinical trial participation of African American and black youth with sickle cell disease and their parents

AU - Omondi, Nancy A.

AU - Ferguson, Stacy E Stickney

AU - Majhail, Navneet S.

AU - Denzen, Ellen M.

AU - Buchanan, George R.

AU - Haight, Ann E.

AU - Labotka, Richard J.

AU - Rizzo, J. Douglas

AU - Murphy, Elizabeth A.

PY - 2013/5

Y1 - 2013/5

N2 - African Americans and Blacks have low participation rates in clinical trials and reduced access to aggressive medical therapies. Hematopoietic cell transplantation (HCT) is a high-risk but potentially curative therapy for sickle cell disease (SCD), a disorder predominantly seen in African Americans. We conducted focus groups to better understand participation barriers to HCT clinical trials for SCD. Nine focus groups of youth with SCD (n=10) and parents (n=41) were conducted at 3 sites representing the Midwest, South Atlantic, and West South Central US. Main barriers to clinical trial participation included gaps in knowledge about SCD, limited access to SCD/HCT trial information, and mistrust of medical professionals. For education about SCD/HCT trials, participants highly preferred one-on-one interactions with medical professionals and electronic media as a supplement. Providers can engage with sickle cell camps to provide information on SCD/HCT clinical trials to youth and local health fairs for parents/families. Youth reported learning about SCD through computer games; investigators may find this medium useful for clinical trial/HCT education. African Americans affected by SCD face unique barriers to clinical trial participation and have unmet HCT clinical studies education needs. Greater recognition of these barriers will allow targeted interventions in this community to increase their access to HCT.

AB - African Americans and Blacks have low participation rates in clinical trials and reduced access to aggressive medical therapies. Hematopoietic cell transplantation (HCT) is a high-risk but potentially curative therapy for sickle cell disease (SCD), a disorder predominantly seen in African Americans. We conducted focus groups to better understand participation barriers to HCT clinical trials for SCD. Nine focus groups of youth with SCD (n=10) and parents (n=41) were conducted at 3 sites representing the Midwest, South Atlantic, and West South Central US. Main barriers to clinical trial participation included gaps in knowledge about SCD, limited access to SCD/HCT trial information, and mistrust of medical professionals. For education about SCD/HCT trials, participants highly preferred one-on-one interactions with medical professionals and electronic media as a supplement. Providers can engage with sickle cell camps to provide information on SCD/HCT clinical trials to youth and local health fairs for parents/families. Youth reported learning about SCD through computer games; investigators may find this medium useful for clinical trial/HCT education. African Americans affected by SCD face unique barriers to clinical trial participation and have unmet HCT clinical studies education needs. Greater recognition of these barriers will allow targeted interventions in this community to increase their access to HCT.

KW - Clinical trial participation

KW - Focus groups

KW - Hematopoietic cell transplantation

KW - Mistrust

KW - Sickle cell disease

UR - http://www.scopus.com/inward/record.url?scp=84878650616&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84878650616&partnerID=8YFLogxK

U2 - 10.1097/MPH.0b013e31828d5e6a

DO - 10.1097/MPH.0b013e31828d5e6a

M3 - Article

C2 - 23612380

AN - SCOPUS:84878650616

VL - 35

SP - 289

EP - 298

JO - Journal of Pediatric Hematology/Oncology

JF - Journal of Pediatric Hematology/Oncology

SN - 1077-4114

IS - 4

ER -